NewsWatch: Moderna and SpaceX highlighted by a fast-growing U.S. fund traded in London

Baillie Gifford U.S. Development Belief devoted a lot of its half-yearly report back to speaking up the prospects of biotech Moderna and rocket launcher SpaceX, two of its investments that helped elevate its web asset worth surge throughout the time-frame.

Learn Full Story

Newest posts by Market Watch (see all)